BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:EB-SELECT Dual-Target CAR-NK Cells readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of EB-SELECT Dual-Target CAR-NK Cells\, from
  ClinicalTrials.gov estimates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07410494-3252@assetmemo.bio
DTSTAMP:20261121T005943Z
DTSTART;VALUE=DATE:20271228
DTEND;VALUE=DATE:20271229
SUMMARY:EB-SELECT Dual-Target CAR-NK Cells: Phase 1/2 readout est. (NCT0741
 0494)
DESCRIPTION:EB-SELECT Dual-Target CAR-NK Cells\, phase 1/2\, Solid Tumors.\
 nStudy: Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Ce
 ll Therapy for Advanced Solid Tumors\nEstimated primary completion: 28 Dec
 ember 2027. This is a ClinicalTrials.gov estimate\, not a confirmed readou
 t date\, and it can move.\nDrug page: https://assetmemo.bio/drug/eb-select
 -dual-target-car-nk-cells#upcoming-events\nRegistry record: https://clinic
 altrials.gov/study/NCT07410494
URL:https://assetmemo.bio/drug/eb-select-dual-target-car-nk-cells#upcoming-
 events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
